Amid six years of near-zero interest rates, income-hungry investors have increasingly turned to dividend-paying stocks.
Companies have taken note by sweetening distributions. This year is on track to set a milestone for total dividend payouts.
Forty dividend stocks boosted payouts last week, including Bristol-Myers Squibb (NYSE: BMY) and General Electric (NYSE: GE).
Following are 25 notable hikes from the week ending Dec. 12.
Amid six years of near-zero interest rates, income-hungry investors have increasingly turned to dividend-paying stocks.
Companies have taken note by sweetening distributions. This year is on track to set a milestone for total dividend payouts.
Forty dividend stocks boosted payouts last week, including Bristol-Myers Squibb (NYSE: BMY) and General Electric (NYSE: GE).
Following are 25 notable hikes from the week ending Dec. 12.
Start the conversation
Leave a Reply
One of the reasons biotech stocks can be your portfolio’s biggest winners is because of the massive profits companies see after releasing a blockbuster drug – especially with the exorbitantly high prices of this year’s new treatments.
Here are a closer look at the priciest drugs – and the biotech stocks behind them…
Start the conversation